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Abstract
It has been more than 100 years since the realization that microbes are capable of causing disease.
In that time, we have learned a great deal as to how each organism has adapted to the immune
system so as to avoid elimination. As well, we have also learned an immense amount since Louis
Pasteur first proposed that the solution to infectious diseases was to culture the microbes and
attenuate their virulence, so as to use them as vaccines. From the optimism and promise of the 19th
century and immunization as the ultimate answer to the invasion by the microbial world, to the
scientific realities of the 21st century, it is of interest to retrace the steps of the earliest
microbiologists cum immunologists, to realize how far we've come, as well as how far we yet have
to go. This editorial focuses on the history of anthrax as a microbial disease, and the earliest efforts
at producing a vaccine for its prevention.
Editorial
"In France, one can be an anarchist, a communist or a nihilist,
but not an anti-Pastorian. A simple question of science has been
made into a question of patriotism."
August Lutand
"Pasteur et la Rage"
1887





To continue the series of "The Classics of Immunology" we
turn next to Louis Pasteur's development of the live atten-
uated anthrax vaccine, first published in 1881 [1]. In this
publication, Pasteur claimed that he could attenuate the
anthrax organism by simply culturing it in air at elevated
temperatures. Together with his announcement a year
previously of a vaccine for chicken cholera [2], he thus
introduced the concept of attenuating the virulence of
organisms so that they could be used as live vaccines.
Audaciously, he speculated that all microbial diseases
could be prevented this way: one only had to learn how to
culture the offending agent. Of course we now know that
it is not quite as simple as Pasteur originally claimed, par-
ticularly for bacterial infections. A brief review of this
interesting period in early immunology is warranted
before one can fully appreciate our present day knowl-
edge.
When the anthrax spores were sent through the mail soon
after the terrorist attacks on 9/11/2001, I was perplexed. I
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really had no idea what disease, or diseases, that were
caused by the anthrax microbe. I vaguely recalled from my
medical school days that the anthrax microbe is a Gram-
positive rod. I also recalled that Louis Pasteur had devel-
oped a vaccine against anthrax, but that was about all that
I could remember. Accordingly, I consulted my microbiol-
ogy texts and went on-line, to see what I could learn.
From my texts I learned that the anthrax organism has the
unusual property of undergoing a metamorphosis from a
multiplying vegetative bacteria into a spore  (from the
Greek, sporos = seed), which is defined as an inactive rest-
ing or resistant form produced within the body of a bacte-
rium.
I also learned that anthrax was the first disease actually
proven to be caused by a microbe, by Dr. Robert Koch,
who reported on his experimental findings in 1876 [3].
This piece of information really piqued my interest,
because I had no idea that anthrax was so central to the
history of medicine. Like most other physicians of my
generation, I had never seen nor heard of an actual case of
anthrax. However, I did know that anthrax was often men-
tioned as a possible bio-weapon that could be used by ter-
rorists, but I did not know why it was so dangerous, or
exactly what symptoms were produced by the infection.
I remembered visiting one of my friends at the Frederick
Cancer Research Facility (FCRF) in Frederick Maryland in
the 1970's. The FCRF was originally Fort Dietrich, which
from 1943 to 1969 was the U.S. Army base devoted to
chemical and biological warfare research. My friend
pointed out a large 5–6-story building that had all of the
windows and doorways covered over with concrete
blocks. This building had housed all the anthrax research,
and it was still contaminated by anthrax spores, which
were extremely deadly, so that the building had been her-
metically sealed, rather than razed, when President Nixon
discontinued chemical and biological warfare research. As
far as I know, that building is still there in Frederick.
To learn more about Robert Koch and anthrax, I turned to
a book by Eli Metchnikoff, published originally in 1905,
entitled "The Founders of Modern Medicine: Pasteur,
Koch, and Lister" [4]. Metchnikoff was a Russian zoolo-
gist, who observed the phenomenon of phagocytosis for
the first time, while studying starfish larvae off the coast of
Naples in the 1870's [5]. Subsequently, in 1885, he was
recruited by Pasteur to become the first Chef de Service at
the newly formed Institut Pasteur in Paris, where he
championed the idea that cells actually are responsible for
immunity.
Beginning with Ignaz Semmelweis' observations on the
possible cause of puerperal fever (childbed fever) in 1850
[6], the notion that small microscopic living things might
cause disease and death began. Then, Louis Pasteur's dem-
onstration in 1857 that fermentation of lactic acid into
alcohol and carbon dioxide was actually caused by living
organisms (animal infusoria), and not by the then popu-
lar theory of "spontaneous generation", set the stage for
the importance of microbes in everyday processes [7].
Subsequently, Joseph Lister's 1867 descriptions of the use
of antiseptics in the practice of treatment of compound
fractures and at surgery [8,9], promoted a growing notion
that removal of microbes isolated from wounds and other
degenerative tissues could improve the outcome of the
patient. However, the most common belief still held was
that any microbes found in suppurating tissues were the
result and not the cause of the fetid, morbid state. The
morbidity was thought to arise spontaneously via chemi-
cal reactions. Any association with living microbes was
considered fortuitist.
In the words of Metchnikoff,
"A powerful impulse was necessary to change this inchoate idea
of organized (chemical) ferments into a rigorously proven sci-
entific truth that microbes were responsible (for putrifaction
and disease). Robert Koch started such an impetus in his 1876
paper on anthrax. This young health officer in the little city of
Wolstein, a god-forsaken hole in Posen (Prussia), suddenly
came into the limelight of science. His work was indeed a model
of true scientific creativeness. Living in a region in which
anthrax was endemic, he set about to study it, without the help
of laboratory or library, and was always thrown back on his own
resources. He worked in his own rooms where for lack of gas
illumination he was obliged to use a petroleum lamp. By means
of plates covered with moist sand he constructed a semblance of
an apparatus for growing cultures of bacteria. Nevertheless, he
achieved results superior to anything yet accomplished. He was
the first to succeed in changing the thread-like microscopical
corpuscles identified by others (in France) into identifiable fil-
aments (chains of rods) and then into beads consisting of
minute grains, the spores. This great discovery of the spore of
anthrax removed all doubts regarding the role of bacteria in the
causation of anthrax, for it illuminated all points hitherto left
unexplained."
Throughout medieval times, anthrax was a disease prima-
rily of livestock, and it still is considered so, which
explains why I was unfamiliar with it. In humans, the
most common affliction is a skin inflammation that
matures into a very characteristic ugly black eschar, from
whence the disease was named from the Greek: anthrax =
coal, carbuncle. In the 19th and early 20th centuries, cutane-
ous anthrax was also known as "wool sorters disease",
because farmers and woolen workers would contract it
from handling animals and wool contaminated with
anthrax spores. For the livestock industry, anthrax was aMedical Immunology 2005, 4:5 http://www.medimmunol.com/content/4/1/5
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serious problem, in that many animals would succumb to
a more severe disease manifested by both gastrointestinal
and pulmonary symptoms. Once animals died and their
corpses were allowed to disintegrate in a pasture, it was
well known that the particular pasture was thereafter sus-
pect, in that the reintroduction of fresh animals in the
spring often resulted in the reappearance of the disease.
Thus, as a result of Koch's experiments, it was realized that
the ability of the microbe to sporulate enabled it to with-
stand the harsh temperatures and conditions that often
occur during the winter months.
Nowadays the livestock industry is protected from anthrax
by vaccination. This protection of farm animals extends to
farmers and other humans, such as textile workers and
vets, so that anthrax infection of humans has become
exceedingly rare, especially since the time of Koch. How-
ever, what is the situation with an anthrax vaccine for
humans? In our country, the only vaccine available is only
being administered to soldiers. Since the postal anthrax
scare of 2001, the Administration, via the Defense Depart-
ment ordered all new recruits to receive the vaccine. How-
ever, the vaccine is reportedly not 100% effective, requires
6 injections over a period of a year and a half, and is asso-
ciated with side effects/toxicities that have led some army
personnel to refuse it.
Louis Pasteur introduced a live attenuated anthrax vaccine
more than 100 years ago. So why is the currently used vac-
cine so cumbersome and toxic? Also, is the current vaccine
similar to the one introduced by Pasteur? Is the vaccine
that is used for animals the same as the one used for
humans?
When contemplating these questions, I remembered that
in 1998, while in France, I happened to read an article in
Le Figaro, which announced that the anthrax vaccine
introduced by Pasteur in 1881 was in fact not the live
attenuated vaccine that Pasteur had suggested he used at
the time. Instead, the vaccine was a chemically killed vac-
cine that had been developed and introduced by one of
Pasteur's rivals, a Dr. Toussaint, who was a veterinarian
from Toulouse, France.
To understand the implications of the announcement by
a leading French newspaper that the icon of the French sci-
entific accomplishment and integrity had committed
what amounts to scientific fraud, it is necessary to research
the source documents of Pasteur's experiments and publi-
cations.
After Pasteur, the chemist, had dispensed with the theo-
ries of "spontaneous generation" as responsible for the
chemical changes responsible for fermentation of sugar
into alcohol in 1857, he went on over the next 20-years to
perform a series of careful microbiological experiments in
applied science in studies of bacterial contamination con-
fronting the silk worm industry, as well as the wine, vine-
gar and beer industries, thereby establishing the
importance of microbes for everyday endeavors. In the
process of doing so, he became almost deified in France,
if not the rest of the world as the icon of a scientist.
Thus, in April of 1878, just two years after Koch's revolu-
tionary publication proving the microbiological cause of
anthrax, Pasteur presented a "Summary" to the Academy
of Sciences, essentially claiming priority of the germ the-
ory of disease [10]. According to Pasteur:
"The only way currently available to science to experimentally
prove that a microscopic organism is the cause of both the illness
itself and its transmission, is to subject the microbe to serial cul-
tures."
Pasteur then goes on to describe his experiments with the
anthrax bacillus, never mentioning that Koch had already
demonstrated the culture of the anthrax microbe two
years earlier. In concluding, he states that:
"I ask the Academy not to dismiss these curious results before I
demonstrate one important theoretical conclusion. We insist on
demonstrating at the start of these studies (that are opening a
whole new world of knowledge) a proof that the cause of
transmissible, contagious and infectious diseases resides essen-
tially and uniquely in the presence of microorganisms."
Not yet two years later, in February of 1880, Pasteur again
presented to the members of the Academy a treatise enti-
tled "Of Infectious Diseases, Especially the Diseases of Chicken
Cholera" [2].
In this presentation, Pasteur first reminded the members
that the theory of spontaneous generation was false, as
demonstrated by his very own experiments performed
more than 20 years previously. He then set the stage by
stating:
"Infectious diseases consist of most of the major disasters, such
as smallpox, scarlet fever, rubella, syphilis, glanders, anthrax,
yellow fever, typhus, and bovine plague."
Pasteur then discussed the phenomenon of vaccination as
introduced by Sir Edward Jenner almost 100 years before
as something already known by the common man, and
essentially claims immunity for all other microbes for
himself:
"The practices of vaccination and variolization have been
known in India for the longest time. Even before Jenner dem-
onstrated the efficacy of vaccinia, people of the countrysideMedical Immunology 2005, 4:5 http://www.medimmunol.com/content/4/1/5
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where he practiced already knew that cowpox protected against
smallpox. The facts about vaccinia are unique, but the facts
about nonrecurrance of virulent diseases are more general. The
organism never expresses twice the effect of chicken pox, scarlet
fever, typhus, plague, smallpox, syphilis and others, as the
immunity lasts for a long time at least."
Pasteur then introduced the problem of chicken cholera,
and mentioned that M. Toussaint, a professor at the veter-
inary school of Toulouse had been the first to culture and
isolate the microbe that he thought to be responsible for
the cause of the disease of chickens. Pasteur went on to say
that he had discovered an improved culture medium for
the microbe, and....
"We can diminish the microbe's virulence by changing the
mode of culturing. This is the crucial point of my subject. I ask
the Academy not to criticize for the time being, the confidence
of my proceedings that permit me to determine the microbe's
attenuation, in order to save the independence of my studies
and to better assure their progress."
With this presentation to the Academy, Pasteur merged
the science of microbiology with that of what subse-
quently became known as immunology for the first time.
As well, this presentation to the public revealed a crucial
aspect of Pasteur's experiments and thinking as to his per-
ception of the importance of his findings. In France at the
time it was common practice to submit a sealed note
(called a pli cachete) on an important scientific discovery
to the Academy of Sciences to secure or protect one's pri-
ority. By comparison, an official patent application (brevet
d'invention) was necessary to establish one's right to the
commercial exploitation of that discovery. Pasteur thus
kept it a secret as to exactly how he had attenuated the vir-
ulence of the chicken cholera microbe for more than 9
months, until October of 1880.
Eventually, Pasteur disclosed that his methods simply
involved culturing the microbe exposed to atmospheric
oxygen for prolonged intervals, i.e. longer than 2–3
months. However, he never explained why oxygen should
weaken the microbe's virulence, especially as the chicken
cholera microbe is an aerobic organism. It is likely that he
did not want to risk others trying to repeat his methods,
both from the standpoint of the fear of their success as
well as their failure.
Pasteur then described using the "live attenuated" cholera
vaccine to immunize animals against lethal challenges of
the microbe, and stated that
" It seems as if the initial microbe inoculations (of the live
attenuated vaccine) have  depleted  a certain element that
healing does not reconstitute and that the absence of which hin-
ders the development of this small organism (when re-inocu-
lated a second, third, and fourth time). This explanation
will without doubt, become general and applied to all infec-
tious diseases.
I would like to point out to the Academy two main consequences
to the facts presented: the hope to culture all microbes and to
find a vaccine for all infectious diseases that have repeatedly
afflicted humanity, and are a major burden on agriculture
and breeding of domestic animals." 
The importance of Pasteur's theory, i.e. that it was possible
to attenuate the virulence of all microbes, simply by pass-
ing them in special culture conditions can only be appre-
ciated by understanding the competition that developed
between Pasteur and Toussaint in the summer of 1880
involving different approaches to the creation of a vaccine
for anthrax.
Pasteur had begun working on a vaccine for anthrax 3
years previously, soon after Koch's announcement on the
isolation of the causative anthrax bacillus [11]. On July
12, 1880, Henri Bouley (a fellow veterinarian and friend
of Toussaint) read before the Academy of Sciences a report
from Toussaint (who was not a member of the Academy),
which described the initial results of his experimental vac-
cine trials. In contrast to Pasteur's "live attenuated" vac-
cine, Toussaint generated his vaccine simply by killing the
bacilli by heating for 10 minutes at 55°C. Using this vac-
cine, Toussaint had conducted trials on 8 dogs and 11
sheep. Of the 8 dogs, 4 had been injected with the vaccine
and had survived a series of 4 successive injections of vir-
ulent live anthrax. By comparison, all 4 unvaccinated dogs
succumbed to the first injection. A similar result was
obtained with the sheep.
In August, while vacationing, Pasteur heard the news of
Toussaint's vaccine experiments from Bouley. He
responded as follows [11]:
"My very good colleague,
Since yesterday morning, when I received your letter, the
extracts of the journals, and the Summary of the Academy of
Sciences-all at the same time -I have been in astonishment and
admiration over the discovery of M. Toussaint-in admiration
that it exists, in astonishment that it can be. It overturns all the
ideas I had on viruses, vaccines etc. I no longer understand any-
thing. Ten times yesterday, I had the idea of taking the train to
Paris. I really cannot believe this surprising fact until I've seen
it, seen it with my own eyes, though the observation that estab-
lishes the fact makes me want to confirm it to my own satisfac-
tion.Medical Immunology 2005, 4:5 http://www.medimmunol.com/content/4/1/5
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The Academy of medicine has thus received a severe lesson. It
will surely have grasped that one does not deal lightly with facts
of this order in public, that contemplation is appropriate in the
face of such solutions to such problems.
I am too moved to write more fully. I have dreamed about it,
both asleep and awake, all through the night.
Best to you and thanks.
L. Pasteur
Pasteur's expression of surprise and agitation makes sense
only in the context of his general theoretical views on dis-
eases and immunity. Because of his successes in his stud-
ies of the metabolism of living microbes, Pasteur naturally
extended his concepts to immunity. Linking immunity
with the biology of microbes, especially the nutritional
requirements of the virulent microbe, he suggested that
the tissues of the invaded host might contain only trace
amounts of some nutrients required for the growth and
survival of the microbe, just as some culture media con-
tained only trace amounts of vital nutrients. If so, the
invading microbe might soon exhaust the supply of these
trace substances, rendering the host an unsuitable
medium for the microbe's subsequent cultivation. Thus,
the host would not support the growth of a subsequent
infection by the virulent microbe, and would be
"immune" (Latin, immunis; free, exempt). Also, an attenu-
ated microbe would be one that had been stressed by cul-
tivation either in vitro or in vivo in an environment that
was limiting in essential nutrients, thereby somehow
loosing its virulence.
Thus, central to Pasteur's conception of immunity, was
the biological activity of a living, if attenuated, microbe
that depleted the host of essential nutrients. It was Tous-
saint's claim that he had in fact produced a "dead" vaccine
against anthrax that moved Pasteur to state that "it over-
turns all the ideas I had on viruses, vaccines, etc."
As one might imagine, given Pasteur's theory, and his
statements already made to the Academy, his lance had
been planted. He could not, and would not, graciously
admit that he was wrong. The story only goes downhill
from this point. In the public critique that Pasteur was
soon to issue against Toussaint's work, his central theoret-
ical concern was precisely the question of "live vs. dead"
vaccines.
In August, 1880, soon after announcing his heat killing
method of vaccine production, Toussaint switched his
procedures and had begun to subject the bacilli to the
action of carbolic acid, which had long been used as a dis-
infectant and had more recently become famous as Joseph
Lister's "antiseptic" of choice for the treatment of surgical
wounds.
Pasteur did not announce the discovery of his own "live
attenuated" anthrax vaccine until February 28, 1881. Of
significance, Pasteur linked his new vaccine with his ear-
lier chicken cholera vaccine by ascribing attenuation in
both cases to the action of atmospheric oxygen. However,
there was an important difference between the production
methods of the two vaccines. Unlike the chicken cholera
microbe, the anthrax bacillus formed spores that "resisted
the attenuating effects of atmospheric oxygen". It had taken
much time and effort to ascertain that a spore-free culture
of anthrax could be produced at a temperature of 42°–
43°C.
Subsequently, on March 21st, Pasteur reported further suc-
cessful results testing his vaccine in sheep, which stimu-
lated a challenge by a veterinarian, Hippolyte Rossignol
from Pouilly-Le-Fort, to test the new vaccine at his farm in
Melun, 40 kilometers from Paris. Examination of Pas-
teur's lab notebooks [11] reveals that he had been con-
ducting small trials, testing his vaccines in animals during
this time, with less than conclusive results as to the protec-
tive efficacy of the live atmospheric oxygen attenuated
vaccine. However, at the same time, Pasteur's lab was test-
ing a vaccine prepared by M. Chamberland, who was
experimenting with a "dead" vaccine prepared by chemi-
cal treatment with potassium-bichromate. In small-scale
tests this vaccine was working.
If Pasteur had failed to accept Rossignol's challenge, he
would certainly have damaged his priority competition
with Toussaint. Moreover, there were already rumors that
Pasteur was really seeking to profit financially from his
"secret remedies" against livestock diseases. Therefore,
Pasteur "impulsively" accepted the challenge and on April
28, 1881, and he signed a detailed and demanding proto-
col, which was performed in May.
There is a wonderfully detailed accounting of the drama of
the public trial that Pasteur publicly presided over on June
2, 1881 [12]. There were more than 200 observers, includ-
ing government officials, local politicians, veterinarians,
farmers, agriculturists, cavalry officers and newspaper
reporters. Of 50 sheep in the trial, half were vaccinated on
May 5th and May 17th, while the other half served as
unvaccinated controls. All of the sheep were then chal-
lenged with a virulent culture of anthrax bacilli on May
31st. Just 3 days later, all of the vaccinated sheep were
alive, while most of the unvaccinated sheep were already
dead, with the remaining obviously very ill.
Only Pasteur and his collaborators knew of the real nature
of the vaccine used for this famous trial. Pasteur had notMedical Immunology 2005, 4:5 http://www.medimmunol.com/content/4/1/5
Page 6 of 6
(page number not for citation purposes)
used the live attenuated vaccine that he had emphasized
was so important for his success with chicken cholera.
Instead, the "dead" vaccine of Toussaint prepared by
Chamberland by treatment with potassium-bichromate
was used [11].
The up-shot of this public demonstration of Pasteur's vac-
cine was that he received credit for developing the first
successful vaccine against anthrax. Toussaint subse-
quently published only 2 more scientific papers before he
died in 1890 at the age of 43, after suffering a mental
breakdown [11]. It was not until 1998, that the French
government officially recognized Toussaint's vaccine as
the first effective vaccine against anthrax.
It is noteworthy that Robert Koch, who became one of
Pasteur's chief competitors, hailed Toussaint as the wor-
thy inventor of vaccination against anthrax, and persist-
ently denigrated Pasteur's contributions to microbiology
[4].
There are many other questions that remain unanswered,
such as the nature of the vaccine that Pasteur's laboratory
supplied to the many people who requested doses for
their animals. Parenthetically, it is noteworthy that the
vaccine was manufactured commercially by Pasteur's
team, and yielded a substantial income for the new Pas-
teur Institute, which was initiated four years later, in 1885
[11]. As well, what of the others in the Pasteur group, all
of who knew of the real nature of the vaccine that was
used at Pouilly-Le-Fort? Probably of most importance,
what became of the concept of attenuating microbes by
exposing them to atmospheric oxygen? Surely, all compe-
tent bacteriologists who worked in the early and mid 20th
century had to know that Pasteur had been wrong, and
that it was impossible to attenuate aerobic microbes by
simply culturing them in the open air. Why was this not
aired?
Fast-forwarding to the present, I have asked Julia Wang
and Michael Roehrl to bring us up-to-date on the present
state of the art of anthrax vaccine research. As detailed in
their excellent review, the nature of the anthrax vaccine
that is in use presently to immunize at-risk wool mill
workers, veterinarians, laboratory workers, livestock han-
dlers, and members of the Armed Service is a cell-free fil-
trate. The vaccine was developed in the 1950s and 1960s
for use in humans and was licensed by the FDA in 1970.
It has undergone extensive testing in monkeys and has
been found to be effective in protecting against pulmo-
nary anthrax after an experimental aerosol challenge.
The remarkable virulence of anthrax, which makes it such
an attractive microbe for bio-warfare, resides in several
unique features, including its capability to sporulate,
thereby surviving extremes of the environment, its cap-
sule, which impairs phagocytosis, and its toxins, as well as
how the toxins interact with and eventually incapacitate
the immune system. A lot has changed since the days of
Pasteur and Toussaint. We are fortunate that now we have
a better understanding of bacteria in general and the
anthrax bacillus in particular. Now it is possible to make
a safe and effective vaccine for such a virulent organism,
based not on a live attenuated vaccine as proposed by Pas-
teur, but a vaccine more like the inactivated preparation
originally developed by Toussaint.
Access to the papers referred to in this editorial can be
obtained at [13]
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